APOP 2.37 ^7% MORE NEWS All Content and Data
Post# of 144418
All Content and Data provided by Third-Parties — Terms of Use
Cellect Biotechnology Gets Clearance to Conduct Trial of Bone Marrow Transplantation Product
MT NEWSWIRES 9:46 AM ET 12/23/2019
Symbol Last Price Change
APOP 2.37down +0.17 (+7.73%)
QUOTES AS OF 10:22:14 AM ET 12/23/2019
09:46 AM EST, 12/23/2019 (MT Newswires) -- Cellect Biotechnology(APOP) said Monday that it has received clearance to perform a clinical trial in the US to determine the safety and tolerability of the ApoGraft technology for haploidentical bone marrow transplantations.
Protocol for the trial was approved by the Institutional Review Board of the Washington University School of Medicine in St. Louis. A total of 18 patients are expected to take part in the initial phase of the study. Enrollment is slated to begin in the first half of next year, the company said.
Price: 2.25, Change: +0.05, Percent Change: +2.27
MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
©http://www.mtnewswires.com Copyright © 2019 MT Newswires. All rights reserved.
APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP